SNN Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$34.07median target· current $30.59 (+11.4%)5 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
47 articles · sorted by datePage 1 of 3 · 47 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio21.39Forward 13.62
EPS (TTM)$1.4370.4% YoY
Profit margin10.1%HEALTHCARE
Market cap$12.89BLarge cap
Valuation
- Forward P/E
- 13.62
- PEG ratio
- 1.21
- P/B
- 2.44
- P/S (TTM)
- 2.09
- EV/EBITDA
- 10.17
Profitability & growth
- ROE (TTM)
- 11.8%
- Operating margin
- 14.0%
- Revenue growth YoY
- 7.4%
- Dividend yield
- 2.6%
- Beta
- 0.68
Last earnings
May 6, 2026 · Estimate $0.00 · Reported $0.00
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Smith & Nephew SNATS Inc
Company profileSmith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- BUILDING 5, WATFORD, UNITED KINGDOM
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Market cap$12.89B
Shares outstanding$421.5M
52W high$37.90
52W low$28.56
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent